[1] Li S, Yang Z, Shen J, et al. Adoptive therapy with CAR redirected T cells for hematological malignancies[J]. Science ChinaLife Sciences, 2016, 59(4): 370-378.
[2] Mohty M, Gautier J, Malard F, et al. CD19 chimeric antigen receptorT cells in Bcell leukemia and lymphoma: current status and perspectives[J]. Leukemia, 2019, 33(12): 2767-2778
[3] 郑敏, 张岚. CART抗肿瘤研究的现状及展望[J].山东大学学报(医学版), 2016, 54(11): 1-7.
[4] Kumar B, Connors T, Farber D. Human T cell development, localization, and function throughout life[J]. Immunity, 2019, 48(2): 202-213.
[5] Costa P, Lahozbeneytez J, Boelen L, et al. Human Tscm cell dynamics in vivo are compatible with longlived immunological memory and stemness[J]. PLOS Biology, 2018, 16(6): 1-22.
[6] Gattinoni L, Lugli E, Ji Y, et al. A human memory Tcell subset with stem celllike properties[J]. Nature Medicine, 2011, 17(10): 1290-1297.
[7] Lugli E, Dominguez M, Gattinoni L, et al. Superior T memory stem cell persistence supports longlived T cell memory[J]. Journal of Clinical Investigation, 2013, 123(2): 594-599.
[8] Li Q, Ito K, Sakakura C, et al. Causal relationship between the loss of Runx3 expression and gastric cancer[J]. Cell, 2002, 109(1): 113-124.
[9] Levanon D, Bettoun D, Harriscerruti C, et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons[J]. EMBO Journal, 2002, 21(13): 3354-3363.
[10] Collins A, Littman D, Taniuchi I. Runx proteins in transcription factor networks that regulate Tcell lineage choice[J]. Nature Reviews Immunology, 2014, 9(2): 106-115.